The l-glutamine analogs, l-albizziin (l-α-amino-β-ureido-propionic acid), S-carbamyl-l-cysteine, and O-carbamyl-l-serine were found to be substrates for purified rat liver glutamine transaminase, and the α-keto acid product formed in each case was found to cyclize to a lactam analogous in structure to the cyclic form of α-ketoglutaramic acid (2-pyrrolidone-5-hydroxy-5-carboxylic acid). Evidence was obtained that the initial product of transamination of albizziin, S-carbamylcysteine, and O-carbamylserine are the corresponding α-keto acids, which were found to be converted by ω-amidase (followed by spontaneous decarboxylation) to β-aminopyruvate, β-mercaptopyruvate, and β-hydroxypyruvate, respectively. Incubation of the glutamine analogs with l-amino acid oxidase from Crotalus adamanteus venom gave the corresponding cyclic lactam forms; the products obtained from albizziin and S-carbamyl-cysteine were rapidly and irreversibly dehydrated in acid or base to yield 2-imidazolinone-4-carboxylic acid and 2-thiazolinone-4-carboxylic acid, respectively. Neither α-ketoglutaramate nor 2-oxazolidone-4-hydroxy-4-carboxylic acid (which was isolated as the corresponding barium salt) was dehydrated under these conditions.
No takes yet. Share an insight, caveat, or question.
Cooper et al. (1973) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: